|
G |
Aoc3 |
amine oxidase, copper containing 3 |
decreases activity |
ISO EXP |
carbamylhydrazine results in decreased activity of AOC3 protein |
CTD |
PMID:10406932 PMID:11543647 |
|
NCBI chr10:86,272,757...86,280,702
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases activity multiple interactions |
EXP |
carbamylhydrazine results in increased activity of CYP19A1 protein [carbamylhydrazine results in increased activity of CYP19A1 protein] which results in increased abundance of Testosterone metabolite |
CTD |
PMID:19788891 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
multiple interactions increases activity |
EXP |
[carbamylhydrazine results in decreased activity of CYP2A1 protein] which results in decreased abundance of Testosterone metabolite; [carbamylhydrazine results in increased activity of CYP2A1 protein] which results in increased abundance of Testosterone metabolite |
CTD |
PMID:19788891 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases activity multiple interactions |
EXP |
carbamylhydrazine results in increased activity of CYP3A2 protein [carbamylhydrazine results in increased activity of CYP3A2 protein] which results in increased abundance of Testosterone metabolite |
CTD |
PMID:19788891 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
carbamylhydrazine inhibits the reaction [Estradiol results in increased activity of ESR1 protein] |
CTD |
PMID:19788891 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
decreases activity |
ISO |
carbamylhydrazine results in decreased activity of GRIN1 protein |
CTD |
PMID:19788891 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Lox |
lysyl oxidase |
decreases activity |
EXP |
carbamylhydrazine results in decreased activity of LOX protein |
CTD |
PMID:19524603 |
|
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
EXP |
[Colchicine co-treated with JTE 013] inhibits the reaction [Taurolithocholic Acid results in decreased activity of ABCC2 protein]; JTE 013 inhibits the reaction [Taurolithocholic Acid affects the localization of ABCC2 protein]; JTE 013 inhibits the reaction [Taurolithocholic Acid results in decreased activity of ABCC2 protein]; JTE 013 inhibits the reaction [Taurolithocholic Acid results in decreased activity of and affects the localization of ABCC2 protein] |
CTD |
PMID:31300867 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
JTE 013 inhibits the reaction [Taurolithocholic Acid results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:31300867 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions |
EXP |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of ATG5 protein] |
CTD |
PMID:37169277 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
EXP |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of COL1A1 protein] |
CTD |
PMID:37169277 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:18612546 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of EGFR protein]; JTE 013 inhibits the reaction [Taurocholic Acid results in increased phosphorylation of EGFR protein] |
CTD |
PMID:26518876 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP |
[JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; [JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [sphingosine 1-phosphate results in increased expression of FN1 protein]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of FN1 protein] |
CTD |
PMID:22406263 PMID:37169277 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
EXP |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of IL18 protein] |
CTD |
PMID:37169277 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of IL6 mRNA]; JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of IL6 mRNA] |
CTD |
PMID:26518876 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
EXP |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of and results in increased lipidation of MAP1LC3B protein] |
CTD |
PMID:37169277 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of MAPK1 protein]; JTE 013 inhibits the reaction [Taurocholic Acid results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:18612546 PMID:26518876 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of MAPK3 protein]; JTE 013 inhibits the reaction [Taurocholic Acid results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:18612546 PMID:26518876 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP2 mRNA]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP2 protein]; JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of MMP2 mRNA]; JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of MMP2 protein] |
CTD |
PMID:26518876 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 protein]; JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of MMP9 mRNA]; JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of MMP9 protein] |
CTD |
PMID:26518876 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
EXP |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of NLRP3 protein] |
CTD |
PMID:37169277 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
multiple interactions |
EXP |
JTE 013 inhibits the reaction [Taurolithocholic Acid results in increased activity of PRKACA protein] |
CTD |
PMID:31300867 |
|
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
JTE 013 inhibits the reaction [Simvastatin promotes the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 protein]; JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of PTGS2 protein]; JTE 013 promotes the reaction [Suramin inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]]; Suramin promotes the reaction [JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]] |
CTD |
PMID:18612546 PMID:26518876 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
JTE 013 inhibits the reaction [sphingosine 1-phosphate affects the localization of RELA protein modified form]; JTE 013 inhibits the reaction [Taurocholic Acid affects the localization of RELA protein modified form] |
CTD |
PMID:26518876 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
multiple interactions |
EXP |
[JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; [JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [sphingosine 1-phosphate results in increased expression of FN1 protein]; [JTE 013 binds to and results in decreased activity of S1PR2 protein] results in decreased susceptibility to [sphingosine 1-phosphate co-treated with Glucose]; [JTE 013 binds to and results in decreased activity of S1PR2 protein] which results in decreased susceptibility to sphingosine 1-phosphate; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of S1PR2 protein] |
CTD |
PMID:22406263 PMID:37169277 |
|
NCBI chr 8:19,503,276...19,514,169
Ensembl chr 8:19,502,627...19,523,574
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of TNF mRNA]; JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of TNF mRNA] |
CTD |
PMID:26518876 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
multiple interactions decreases activity |
ISO |
Nitrofurantoin inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Nitrofurantoin results in decreased activity of ABCB11 protein |
CTD |
PMID:24014644 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases activity |
ISO |
Nitrofurantoin results in decreased activity of ABCB4 protein |
CTD |
PMID:28437613 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
affects transport increases export affects abundance multiple interactions increases transport affects response to substance increases secretion |
ISO EXP |
ABCG2 protein affects the transport of Nitrofurantoin ABCG2 protein results in increased export of Nitrofurantoin ABCG2 protein affects the abundance of Nitrofurantoin chrysin inhibits the reaction [ABCG2 protein results in increased transport of Nitrofurantoin]; Nitrofurantoin inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride] ABCG2 affects the susceptibility to Nitrofurantoin ABCG2 results in increased secretion of Nitrofurantoin ABCG2 protein results in increased secretion of Nitrofurantoin chrysin inhibits the reaction [ABCG2 protein affects the transport of Nitrofurantoin]; Elacridar inhibits the reaction [ABCG2 protein affects the transport of Nitrofurantoin] |
CTD |
PMID:15709111 PMID:15722455 PMID:17093006 PMID:17785426 PMID:18799806 PMID:19105722 PMID:19732493 PMID:26907376 More...
|
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Agt |
angiotensinogen |
decreases activity |
EXP |
Nitrofurantoin results in decreased activity of AGT protein |
CTD |
PMID:1313237 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
increases expression |
EXP |
Nitrofurantoin results in increased expression of ALDOA mRNA; Nitrofurantoin results in increased expression of ALDOA protein |
CTD |
PMID:11841787 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Cat |
catalase |
decreases activity |
ISO EXP |
Nitrofurantoin results in decreased activity of CAT protein |
CTD |
PMID:1313237 PMID:9000262 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cntf |
ciliary neurotrophic factor |
multiple interactions |
ISO |
Nitrofurantoin inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT1 protein]; Nitrofurantoin inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT3 protein]; Rotenone promotes the reaction [Nitrofurantoin inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT1 protein]]; Rotenone promotes the reaction [Nitrofurantoin inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT3 protein]] |
CTD |
PMID:15748169 |
|
NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO EXP |
Nitrofurantoin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] |
CTD |
PMID:18493746 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
Nitrofurantoin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] |
CTD |
PMID:18493746 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions increases expression |
ISO |
NFE2L2 protein affects the reaction [Nitrofurantoin results in increased expression of GCLC protein]; POR protein affects the reaction [Nitrofurantoin results in increased expression of GCLC protein] |
CTD |
PMID:34021431 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity multiple interactions |
EXP ISO |
Nitrofurantoin results in decreased activity of GSR protein [Nitrofurantoin co-treated with GSR protein] affects the metabolism of Glucose |
CTD |
PMID:1313237 PMID:1901343 PMID:9000262 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases activity |
EXP |
Nitrofurantoin results in increased activity of HIF1A protein |
CTD |
PMID:11841787 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP |
Nitrofurantoin results in increased expression of HMOX1 mRNA |
CTD |
PMID:7626009 PMID:11841787 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
increases activity |
ISO |
Nitrofurantoin results in increased activity of HSF1 protein |
CTD |
PMID:34170685 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
increases expression |
EXP |
Nitrofurantoin results in increased expression of HSPA8 mRNA |
CTD |
PMID:7626009 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
Nitrofurantoin results in increased expression of JUN mRNA |
CTD |
PMID:7626009 PMID:11841787 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
increases expression |
EXP |
Nitrofurantoin results in increased expression of LMCD1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
NFE2L2 protein affects the reaction [Nitrofurantoin results in increased expression of GCLC protein]; Nitrofurantoin results in increased expression of and affects the localization of NFE2L2 protein; POR protein affects the reaction [Nitrofurantoin results in increased expression of NFE2L2 protein] |
CTD |
PMID:34021431 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases response to substance affects reduction |
ISO |
NQO1 protein results in increased susceptibility to Nitrofurantoin NQO1 protein affects the reduction of Nitrofurantoin |
CTD |
PMID:9310146 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Orm1 |
orosomucoid 1 |
increases expression |
EXP |
Nitrofurantoin results in increased expression of ORM1 mRNA; Nitrofurantoin results in increased expression of ORM1 protein |
CTD |
PMID:11841787 |
|
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
|
|
G |
Por |
cytochrome p450 oxidoreductase |
increases metabolic processing affects metabolic processing multiple interactions |
ISO EXP |
POR protein results in increased metabolism of Nitrofurantoin POR protein affects the metabolism of Nitrofurantoin diphenyleneiodonium inhibits the reaction [POR protein affects the metabolism of Nitrofurantoin]; NADP affects the reaction [POR protein affects the metabolism of Nitrofurantoin]; Nitrofurantoin inhibits the reaction [POR protein results in increased metabolism of Misonidazole] POR protein affects the reaction [Nitrofurantoin results in increased expression of GCLC protein]; POR protein affects the reaction [Nitrofurantoin results in increased expression of NFE2L2 protein] |
CTD |
PMID:6802140 PMID:18206659 PMID:34021431 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
Nitrofurantoin inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT1 protein]; Rotenone promotes the reaction [Nitrofurantoin inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT1 protein]] |
CTD |
PMID:15748169 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions increases expression increases activity |
ISO EXP |
Nitrofurantoin inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT3 protein]; Rotenone promotes the reaction [Nitrofurantoin inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT3 protein]] Nitrofurantoin results in increased expression of STAT3 mRNA Nitrofurantoin results in increased activity of STAT3 protein |
CTD |
PMID:11841787 PMID:15748169 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
increases expression |
EXP |
Nitrofurantoin results in increased expression of TGFB2 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of CCNE1 mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
affects binding |
EXP |
Nitrofurazone binds to GSK3B protein |
CTD |
PMID:18222664 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of HRAS mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[Nitrofurazone co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO |
Nitrofurazone results in increased expression of IL1B mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[Nitrofurazone co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Iyd |
iodotyrosine deiodinase |
multiple interactions |
ISO |
Nitrofurazone inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of JUN mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases expression |
EXP |
Nitrofurazone results in decreased expression of LHB protein |
CTD |
PMID:11548123 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Mir128-1 |
microRNA 128-1 |
increases expression |
EXP |
Nitrofurazone results in increased expression of MIR128-1 mRNA |
CTD |
PMID:32418910 |
|
NCBI chr13:39,699,449...39,699,530
Ensembl chr13:39,699,449...39,699,530
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression multiple interactions |
EXP |
Nitrofurazone results in increased expression of MYC mRNA Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of MYC mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
EXP |
[Nitrofurazone co-treated with POR protein co-treated with Copper] results in increased abundance of 8-Hydroxy-2'-Deoxyguanosine; Nitrofurazone inhibits the reaction [POR protein results in increased metabolism of Misonidazole] |
CTD |
PMID:6802140 PMID:15488632 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Prl |
prolactin |
decreases expression |
EXP |
Nitrofurazone results in decreased expression of PRL protein |
CTD |
PMID:11548123 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Tgfa |
transforming growth factor alpha |
increases expression multiple interactions |
EXP |
Nitrofurazone results in increased expression of TGFA mRNA Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of TGFA mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of TNF mRNA] |
CTD |
PMID:15945272 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases mutagenesis |
ISO |
Nitrofurazone results in increased mutagenesis of TP53 gene |
CTD |
PMID:15488632 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
3-aminopyridine-2-carboxaldehyde thiosemicarbazone results in increased expression of H2AX protein |
CTD |
PMID:25130544 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Prdx3 |
peroxiredoxin 3 |
increases oxidation |
ISO |
3-aminopyridine-2-carboxaldehyde thiosemicarbazone results in increased oxidation of PRDX3 protein |
CTD |
PMID:21195754 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Rrm2b |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
multiple interactions |
ISO |
[Cisplatin co-treated with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone] results in increased expression of RRM2B protein |
CTD |
PMID:20954859 |
|
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
|
|
G |
Txn2 |
thioredoxin 2 |
increases oxidation multiple interactions |
ISO |
3-aminopyridine-2-carboxaldehyde thiosemicarbazone results in increased oxidation of TXN2 protein [3-aminopyridine-2-carboxaldehyde thiosemicarbazone binds to Iron] which results in increased oxidation of TXN2 protein |
CTD |
PMID:21195754 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|